GeneDx Holdings Corp - SIC # 2835 - IN VITRO AND IN VIVO DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
WGS Nasdaq 2835 https://sema4.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for GeneDx Holdings Corp

Why Shares of GeneDx Dropped Wednesday - Mar 22nd, 2023 8:36 pm
GeneDx Holdings Corp. (NASDAQ:WGS) Q4 2022 Earnings Call Transcript - Mar 21st, 2023 1:07 am
GeneDx Announces Progress on GUARDIAN Study and Promise of Early Genomic Testing to End Rare Disease “Diagnostic Odyssey” - Mar 20th, 2023 12:45 pm
The 7 Worst Stocks to Buy Now - Mar 18th, 2023 10:48 pm
GeneDx Presents New Data at ACMG Demonstrating the Benefits of Exome Sequencing Over Chromosomal Microarray - Mar 16th, 2023 12:45 pm
GeneDx Reports Fourth Quarter and Full Year 2022 Financial Results and Business Highlights - Mar 14th, 2023 8:16 pm
GeneDx to Participate in the Cowen 43rd Annual Healthcare Conference - Mar 1st, 2023 12:30 pm
GeneDx honors Rare Disease Day and announces presentations and research at the 2023 American College of Medical Genetics and Genomics Annual Clinical Genetics Meeting - Feb 28th, 2023 1:30 pm
GeneDx to Report Fourth Quarter and Full Year 2022 Financial Results on Tuesday, March 14th, 2023 - Feb 21st, 2023 9:30 pm
GeneDx Rare Disease Data Demonstrates Utility in Drug Candidate Identification for Common Diseases - Feb 16th, 2023 1:30 pm
GeneDx Announces Closing of Underwritten Public Offering and Concurrent Registered Direct Offering - Jan 31st, 2023 9:15 pm
GeneDx Makes Significant Industry-Wide Contributions to New Disease Gene Discovery - Jan 30th, 2023 1:30 pm
GeneDx Holdings Announces Pricing Of A $150 Million Underwritten Public Offering Of Class A Common Stock And Concurrent Registered Direct Offering - Jan 27th, 2023 11:00 am
GeneDx Announces Proposed Underwritten Public Offering of Class a Common Stock and Concurrent Registered Direct Offering - Jan 26th, 2023 9:53 pm